{"id":66991,"date":"2025-09-30T11:40:00","date_gmt":"2025-09-30T11:40:00","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=66991"},"modified":"2025-10-14T04:31:23","modified_gmt":"2025-10-14T04:31:23","slug":"relationship-between-autoimmune-and-metabolic-disease-in-current-prospectus","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol18no3\/relationship-between-autoimmune-and-metabolic-disease-in-current-prospectus\/","title":{"rendered":"Relationship Between Autoimmune and Metabolic Disease in Current Prospectus"},"content":{"rendered":"

Introduction <\/strong><\/p>\n

Thyroid dysfunction is mostly associated with weight gain along with changes in body temperature, metabolism rate, expenditure of energy, intake of food, level of glucose, and lipid metabolism. Thyroid disorders, comprising autoimmune thyroid diseases (AITDs) and thyroid dysfunctions, are becoming more common these days. Hyperthyroidism and hypothyroidism are examples of thyroid dysfunctions.1<\/sup> The extended effect of hypothyroidism causes severe health problems due to the essential role of thyroid hormone which restrains various parameters of physiological and assures bodily equilibrium which elevates the possibility of Dysmetabolic syndrome, reproductive health problems, and CVD.2,3,4<\/sup> Thyroid disorder has very frequent occurrence in females during the reproductive period span this disorder mainly occurs due to the origin of autoimmune hyperthyroidism as being part of Grave\u2019s disease. (GD).5 <\/sup>Many studies show that being overweight can elevate the thyroid gland function and majorly increase the thyrotropin collection. It also changes the content between the tri-iodothyronine and thyroxine, though within the normal range. Research indicates a favorable association between obesity and serum thyrotropin levels, which affect thyroid functions and tri-iodothyronine (T3) in Individuals euthyroid, indicating probable effect the influence of Obesity affects hypothalamic-pituitary function\u2014Axis of thyroid and exertion of deiodinases. 6,7]<\/sup>Fluctuation in the Ductless gland even if they are in the normal range can exacerbate metabolic Conditions and progress the disease in the thyroid gland It is important to note in this context that components have been positively correlated with elevated TSH and T3 levels of metabolic syndrome, particularly elevated serum TSH levels have been connected to thyroid cancer risk. 8,9<\/sup>Consequently, taking into account the intricacy of the pathophysiology of obesity and the effects of this condition on the thyroid the main aim of this review is to bring recent information to the exact mechanisms underlying the thyroid’s alterations function in those who are stout.<\/p>\n

Correlation between Thyroid and Stoutnesss<\/strong><\/p>\n

Nowdays, the prevalence of obesity with thyroid are growing with growing ages these are\u00a0\u00a0 maybe with changes in lifestyle not following the healthy lifestyle , lacking energy expenditure in term of over eating ,hormonal imbalance these are common factors through which we can correlate with stoutness and thyroid .The correlation between thyroid and stoutness are better understand by the flow chart diagram.<\/p>\n\n\n\n
\"\"<\/td>\nFigure 1: This Flow chart define the correlation of obesity with thyroid in various possible manner.<\/strong>Click here to view Figure\u00a0<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Role of Hyperleptinemia<\/strong><\/p>\n

Generally, in stoutness, the occurrence of hyperleptinemia is a very significant factor regarding the evolution in the hypo-thalamic thyroid axis of the pituitary. It happens to control leptin, a role which is influenced by the thyrotropin and releasing hormones and gets the combination of an arcuate, nucleus (indirect route) or with a direct route which is the nucleus of the paraventricular hypothalamic region increases stimulate the hormone of thyroid production by the gland of pituitary that may approve an increased in the blood levels of this hormone in stout persons.10<\/sup> In the Nucleus of the Paraventricular hypothalamic, leptin acts through a receptor of ObRb that progresses the phosphorylation of stenography factor STAT3 this pathway promotes the binding of regions which enhances the gene coding for TRH. Leptin inhibits neurons that produce Protein related to Agouti (AgRP) and activates a subset of the arcuate nucleus which is located in neurons that express proopiomelanocortin (POMC).NPJ or neuropeptide Y. This action results in higher output of the hormone Alpha melanocyte stimulating the hormone (alpha MSH), It is consequently capable of inducing hypothalamic neurons to express TRH by binding to the receptor for melanocortin 4 (MC4-R). 11,12<\/sup>Leptin seems to enhance the metabolic function of the hormone and thyroid by promoting the activity of a deiodinase enzyme in distinct tissue.13<\/sup>According to this, it’s very crucial to mention here that activity changes in enzymes mainly occur in stoutness, with activity in a brown adipose tissue D2 activity and the pituitary being shown to be reduced, and D1 activity increasing in the liver, kidney, and thyroid. 14,15<\/sup> In some stout subjects high circulating leptin levels, it seems that it can also elevate the serum level of hormones such as T3 AND T4 concentrations which can show a protection against stoutness by increasing metabolic rate.16,17,18,19,20,21<\/sup><\/p>\n

Role of Inflammation<\/strong><\/p>\n

Latest scenario and experimental data suggest that a strong relation has proven the a two-directional link between obesity and thyroid disease.22.23<\/sup>The average incidence of thyroiditis caused by autoimmune agents and idiopathic hypothyroidism, respectively, was found to be 17.1% and 12.3% in a future study of 783 obese individuals who were mentioned to undergo bariatric surgery.24<\/sup>Obesity and thyroid autoimmunity have connections not just via shared pathogenetic routes but also with epidemiological attributes. A key variable in this relationship is insulin resistance (IR), which affects 15.5\u201346% of obese people.25<\/sup>Consequently, dysregulation of the insulin\/leptin system, an increase in oxLDLc, and amplification of the inflammasome are all related to reduced immune response and metabolic alterations that promote thyroid autoimmunity26,27,28<\/sup>. Particularly, low-grade inflammation results in a spike in IL-1beta production, which plays a major role in the pathological process of Hashimoto’s thyroiditis (HT), by preferring CD4 + T helper cells over pro-inflammatory Th17 fractions29,30,31<\/sup> . It is an appealing note that both rat thyroid cells and human expressing cells are TLRs present on their surface, and these receptors possess the capacity to directly bind “danger molecules” that are both endogenous and foreign, rapidly initiating the innate immune system. The hypothesis that thyroid damage to tissues is associated with the innate immune response is supported by many experimental findings. Damage to thyroid cells initiates the generation of intracellular proteins that antigen-presenting cells (APC) might identify. This stimulates the acquired immune response, which intensifies the damage to thyroid cells and ultimately results in the demise of thyroid tissue. 32,33,34<\/sup>Another significant element of the proposed reciprocal interaction between the thyroid immune mechanism and obesity is thyroid hormone. Any clinical condition that results in changed thyroid hormone levels could have an impact on how much the immune system and inflammation are activated. However, changes in thyroid hormone levels could be advantageous for inflammation, atherosclerosis, and obesity. According to recent research, triiodothyronine negatively affects the function of macrophages and NLR inflammatory enzymes. On the other hand, hypothyroid individuals may experience increased inflammatory and immunological responses when their thyroxine (T4) levels are low.35,36<\/sup> It binds with the cell membrane and integrin receptor av\u03b23, T4 can also have an extra-genomic effect. This can modulate the immune response by activating signaling pathways such as mitogen-activated protein kinase (MAPK), cyclooxygenase 2 (COX-2), and hypoxia factor one alpha (HIF-1alpha), which leads to inflammasome activate.37<\/sup><\/p>\n

Causes and Changes in Adipose Tissue and Thyroid Dysfunction<\/strong><\/p>\n

Stoutness and the thyroid have a complicated and reciprocal interaction. It is widely acknowledged in the literature that dysfunction either hyper- or hypothyroidism in this gland causes variations in body weight as a result of the involvement of the hormone thyroid which regulates hunger and thermogenesis. However as recent studies have demonstrated, being overweight can also affect thyroid function when hyperthyrotropinemia is present. Irrespective of alterations in T3 and T4 levels, typically seen in stout euthyroid patients.38,39<\/sup>It is true that are thyroid hormone plays a significant role in controlling hunger and energy expenditure. Conversely, secretory products act on the CNS to provide information about the amount of energy reserves, and I could influence the hypothalamus-pituitary-thyroid axis’s activity. 40,41<\/sup>The issue is complicated, and it is made more so by the possibility that patients who are obese may have changes in the thyroid function test, which begs the question if a certain replacement procedure is recommended. According to epidemiological studies, obesity may be connected to a higher future of thyroid cancer. Even if this is connection still up for discussion, it led to a talk about the potential factors that underlie obesity’s impact on thyroid carcinogenesis. This evaluation essay seeks to evaluate pertinent information from the literature and to talk about the prevailing views on these subjects. Notably, decades of study have shown a connection between thyroid hormone concentrations and fluctuations in body weight. 42,43<\/sup> When the hypothalamic-pituitary-thyroid axis regulates the adaptation of both metabolism and thermos-genesis by interacting with adipose tissue. Regulating: i) adipogenesis-related transcription factors of brown adipose tissue or white adipose tissue (WAT). (BAT); ii) genes associated with lipogenesis, or lipid metabolism and oxidation, as well as lipolysis); and iii) genes controlling BAT thermogenesis.44<\/sup>Thyroid hormone affects thermogenesis at the brain’s cortex level as well. The hypothalamus expresses the TR, which modifies the nervous system’s sympathetic output of the BAT 45<\/sup>. It helps due to the unfavorable power balance that exists in thyrotoxic conditions. Nevertheless, the primary pathway for regulating the hypothalamic-pituitary-thyroid axis in stoutness is caused by resistance selective to leptin in the arcuate nucleus of the hypothalamus via means this is adipokine’s direct impact on the paraventricular center.46,47<\/sup><\/p>\n

Inheritance to Thyroid Hormone <\/strong><\/p>\n

A hereditary disease known as inherent to thyroid hormones is indicated by a decrease in the affinity of thyroid receptor ligands for T3, which is linked to an irreversible interaction of receptor co-repressors. The most prevalent type entails \u03b2 receptors (TR\u03b2) mutations marked by increased T3 levels in the serum and T4, as well as normal and slightly elevated TSH levels. And the other hand, \u03b1 receptor (TR\u03b1) degradation encourages an increase in TSH, and T4 continues to be normal in serum T3, whereas T3 is linked to elevated BMI and cholesterol.[48]<\/sup>.Extensive research has been carried out on resistance to TH (RTH), a disease wherein TR\u03b2 demonstrates a reduced capacity of binding T3 or corepressor binding remains unopposed through ligands 49<\/sup>. The Patients usually show slightly higher serum TSH levels but are “inappropriately normal” or elevated blood T4 and T3 concerns. This is because the faulty TR\u03b2 prevents, elevated blood T4 or T3 concentrations from suppressing TSH. With one exception of tachycardia, the accompanying clinical features\u2014goiter and overall euthyroid\u2014are consistent with the high blood T4 and T3 triggering TR\u03b1 in the atria without interference. Additional clinical characteristics that differ between afflicted parties include decreased linear development, deafness, irregularities in the development of bones, and attention deficit disorder.50<\/sup><\/p>\n

Interrelation between thyroid cancer and Body weight<\/strong><\/p>\n

The earliest research that is now available to the 1940s, and It link between obesity and cancer has been studied for a very long time. During the decade of 1987, the Ist<\/sup> recorded stoutness increase was seen, Albanes51<\/sup>. Association regarding the relation between stoutness and thyroid cancer, there are two kinds of observational studies: the first looks for the future of thyroid cancer in stout patients, while the second looks for obesity in thyroid cancer patients. While there is no proof that thyroid cancer causes significant metabolic changes, it is significant to note that stoutness can be an epiphenomenon of the disease. As a result, the second type of study is less relevant. These approaches provide different information and images. The majority of observational research cited in this version involves sizable cohorts of individuals who are obese. 52<\/sup>.Examined Twelve case-control studies conducted in 1990, involving 2056 females or 417 men with thyroid cancer. The results showed that there was no correlation, although a weak one, between the Body mass index at diagnosis and a higher risk of thyroid cancer in females (OR=1.2). Although other writers have demonstrated links between food consumption and the risk of thyroid cancer53<\/sup>. This first assessment focused solely on anthropometric parameters; it excluded information on eating patterns or other potential risk factors for obesity and cancer. Still, it offered the justification for more research. There wasn’t much research at the time concentrating on the processes of thyroid tumors linked to obesity. [54]<\/sup> Thyroid nodules and the thyroid volume are associated directly with body mass index. According to this association, there is also a correlation with insulin resistance. 55<\/sup><\/p>\n

Energy Expenditure and Adipose Tissue<\/strong><\/p>\n

A continuous energy source is necessary for all living things to maintain the stability of their internal environments. Energy-producing substances, primarily fatty acids, and carbs, are collected from the surroundings and kept in storage to provide accessibility in case of malnourishment. To maintain Homoeostasis of energy, supply, and consumption must be maintained in equilibrium. A relative surplus of energy is produced as a result of either a rise in energy consumption or a fall in energy usage, which is obesity’s root cause. The difficulty Scientists and physicians must work to restore equilibrium in a setting that makes individuals more vulnerable to an energy excess. Although constraint can restore equilibrium Increasing energy expenditure is also a function of energy intake aim56.<\/sup> When Brown adipose tissue (BAT) offers a physio-logical model that enables quick increases in energy expenditure, such as during the arousal of a wintering mammal. It is a discovery that BAT in mature human beings implies that recognizing or pursuing methods to increase BAT energy consumption aids in helping obese persons regain their energy balance. This Examines how thyroid hormone signaling is examined in Thermal genesis triggered by BAT; and investigates the relationship between type 2 deiodinase (D2) and BAT. The D2 is an important BAT function regulation and protein-uncoupling -1 (Ucp1) induction and is required for the appropriate growth of BAT or brown adipocyte differentiation. D2- Adults can express BAT, and recent findings of Its application in physiology and medicine could grow this area of expertise. 56<\/sup>Unlike white adipose tissue, which generally stores and discharges energy in response to the demand of systemic, brain-associated tissue (BAT) specialist tissue that energy by producing heating. It is a distinct function that the white and brown adipose tissue sustain and also visible the differences in their structures\u2014BAT has thick mitochondrial content, has a robust innervation pattern. While sympathetic fibers are heavily vascularized, There are few mitochondria in white adipose tissue, and it is significantly less vascularized and innervated. Mitochondrial Ucp1, a 32 kDa protein, mediates uncoupling on BAT. Expressed in mitochondria’s inner membrane, it eliminates the inner proton gradient mitochondrial membrane that is not phosphorylated with ADP.4 57<\/sup> The global obesity crisis has increased the importance of comprehending the relationship between thyroid hormone metabolism or BAT function. Currently, obesity treatment aims to lessen power input or raise power use or gratuity to the equilibrium toward the overall body-energy deficit. The majority of obesity treatment strategies emphasize increased physical exercise, which patients find challenging to effectively follow, raising energy consumption is a difficult therapeutic objective. Thus, the application of in BAT, thyroid-hormone signaling plays a crucial different therapeutic objective. 56<\/sup>A prime example of this is the impact of cold exposure on the brown adipose tissue (BAT). Type 2 deiodinase drives a temporary condition of “cellular hyperthyroidism,” which is brought on by activation of the beta 3-adrenergic pathway. Therefore, UCP-1 transcription or mitochondrial membrane permeability was selectively enhanced. , which in turn causes a dissociation between ATP production and mitochondrial respiration. This ultimately promotes a dissociation between ATP production and mitochondrial respiration, leading to an ultra-efficient and timely generation of heat to maintain the core of temperature.TH activity is regulated at the cellular level of a class by enzymes that comprise Selena proteins. There are three enzymes, only type 2 and type 1deiodinase can convert prohormone T4 to active TH T3, allowing for variations in local concern<\/sup> and regulating the hormone action on specific tissues without significantly altering blood levels. With a strong affinity for T4, type two deiodinase is mostly located in the brain, gland of the pituitary, thyroid, muscle, and brown fat. It plays a significant role in the tissue- and time-specific control of thyroid hormone action during thermogenesis.<\/p>\n

Role of Hormones of thyroid in Regulating SIRT1 <\/strong><\/p>\n

Thyroid hormones are not only integral to metabolic regulation but also to gene which expression are modulating. There is a key gene which is influenced by signaling of thyroid hormone is Sirtuin 1 (SIRT1) , which is a NAD+ –<\/sup> dependent deacetylase which known for its anti-aging, anti-inflammatory and metabolic regulatory functions. Various emerging evidence suggests that SIRT1 is essential in mitigating autoimmune responses, which also enhance the metabolic balance. Dysregulation of this occurs due to hypothyroidism which suspected to contribute to onset progression of autoimmune diseases and metabolic disorders 57.<\/sup> A study also emphasizes the role of SIRT1 ,in regulation to appetite and reversing cellular senescence and apoptosis- processes intricately linked with thyroid hormone functions and particularly in metabolic and endocrine balance, there is also correlation between lipid and glucose metabolism with thyroid hormone ,as it plays a important role in this metabolism , this also suggest a indirect connection via share regulatory genes like SIRT1 58,59<\/sup> .<\/p>\n

Conclusion <\/strong><\/p>\n

In the future there is a correlation between thyroid dysfunction and stoutness is registered in all aspects such as in terms of inflammation, adipose tissue, and resistance this disease will show a high impact on the population in the coming years, and usually various studies have been conducted and the study suggested that the prevalence of this disease correlation will become very high in developing countries. In this article the flow chart is also attached which will give more insights about the relationship between thyroid and stoutness in coming year the belief in correlation between these two disease will give remarkable significance and hence the treatment approaches will also get enhanced .Thus, the thyroid hormone status may indirectly influence disease susceptibility through its epigenetic control of SIRT1. This article discusses all the major factors through which we can treat and resist the disease’s commencement.<\/p>\n

Acknowledgement<\/strong><\/p>\n

The authors are thankful to provide all the faculties in Parul Institute of pharmacy and research and Department of Pharmacy (pharmacology), Parul University for their Support.<\/p>\n

Funding Sources<\/strong><\/p>\n

The author(s) received no financial support for the research, authorship, and\/or publication of this article.<\/p>\n

Conflict of Interest<\/strong><\/p>\n

The author(s) do not have any conflict of interest.<\/p>\n

Data Availability Statement<\/strong><\/p>\n

This statement does not apply to this article.<\/p>\n

Ethics Statement<\/strong><\/p>\n

This research did not involve human participants, animal subjects, or any material that requires ethical approval.<\/p>\n

Informed Consent Statement<\/strong><\/p>\n

This study did not involve human participants, and therefore, informed consent was not required.<\/p>\n

Clinical Trial Registration<\/strong><\/p>\n

This research does not involve any clinical trials<\/p>\n

Permission to reproduce material from other sources<\/strong><\/p>\n

Not applicable<\/p>\n

Author contributions<\/strong><\/p>\n

Guno Sindhu: Analysis, Supervision, Resources<\/p>\n

Rakhi Mishra: Review &amp; Editing, Data Collection.<\/p>\n

Rohit Agrahari: \u2013 Review &amp; Editing, Data Collection<\/p>\n

Reference<\/strong><\/p>\n

    \n
  1. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol<\/em>. 2018;14(5):301-316. doi:10.1038\/nrendo.2018.18
    \n    CrossRef<\/a><\/li>\n
  2. Dugbartey AT. Neurocognitive Aspects of Hypothyroidism. Arch Intern Med<\/em>. 1998;158(13):1413. doi:10.1001\/archinte.158.13.1413
    \n    CrossRef<\/a><\/li>\n
  3. Biondi B, Klein I. Hypothyroidism as a Risk Factor for Cardiovascular Disease. Endocrine<\/em>. 2004;24(1):001-014. doi:10.1385\/ENDO:24:1:001
    \n    CrossRef<\/a><\/li>\n
  4. Su X, Peng H, Chen X, Wu X, Wang B. Hyperlipidemia and hypothyroidism. ClinicaChimicaActa<\/em>. 2022;527:61-70. doi:10.1016\/j.cca.2022.01.006
    \n    CrossRef<\/a><\/li>\n
  5. Carl\u00e9 A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Laurberg P. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol<\/em>. 2011;164(5):801-809. doi:10.1530\/EJE-10-1155
    \n    CrossRef<\/a><\/li>\n
  6. B\u00e9try C, Challan-Belval MA, Bernard A, Charri\u00e9 A, Drai J, Laville M, Thivolet C, Disse E. Increased TSH in obesity: Evidence for a BMI-independent association with leptin. Diabetes Metab<\/em>. 2015;41(3):248-251. doi:10.1016\/j.diabet.2014.11.009
    \n    CrossRef<\/a><\/li>\n
  7. Ren R, Jiang X, Zhang X, Guan Q, Yu C, Li Y, Gao L, Zhang H, Zhao J. Association between thyroid hormones and body fat in euthyroid subjects. ClinEndocrinol (Oxf)<\/em>. 2014;80(4):585-590. doi:10.1111\/cen.12311
    \n    CrossRef<\/a><\/li>\n
  8. Marcello MA, Cunha LL, Batista FA, Ward LS. Obesity and thyroid cancer. Endocrine Related Cancer<\/em>. 2014;21(5):T255-T271. doi:10.1530\/ERC-14-0070
    \n    CrossRef<\/a><\/li>\n
  9. Wang X, Liu H, Chen J, Huang Y, Li L, Rampersad S, Qu S. Metabolic Characteristics in Obese Patients Complicated by Mild Thyroid Hormone Deficiency. Hormone and Metabolic Research<\/em>. 2016;48(05):331-337. doi:10.1055\/s-0042-105150
    \n    CrossRef<\/a><\/li>\n
  10. Ghamari-Langroudi M, Vella KR, Srisai D, Sugrue ML, Hollenberg AN, Cone RD. Regulation of Thyrotropin-Releasing Hormone-Expressing Neurons in Paraventricular Nucleus of the Hypothalamus by Signals of Adiposity. Molecular Endocrinology<\/em>. 2010;24(12):2366-2381. doi:10.1210\/me.2010-0203
    \n    CrossRef<\/a><\/li>\n
  11. Hollenberg AN. The Role of the Thyrotropin-Releasing Hormone (TRH) Neuron as a Metabolic Sensor. Thyroid<\/em>. 2008;18(2):131-139. doi:10.1089\/thy.2007.0251
    \n    CrossRef<\/a><\/li>\n
  12. van de Sande-Lee S, Velloso LA. Disfun\u00e7\u00e3ohipotal\u00e2micanaobesidade. ArquivosBrasileiros de Endocrinologia&Metabologia<\/em>. 2012;56(6):341-350. doi:10.1590\/S0004-27302012000600001
    \n    CrossRef<\/a><\/li>\n
  13. Cabanelas A, Lisboa P, Moura E, Pazos-Moura C. Acute Effects of Leptin on 5\u2032-Deiodinases are Modulated by Thyroid State of Fed Rats. Hormone and Metabolic Research<\/em>. 2007;39(11):818-822. doi:10.1055\/s-2007-991169
    \n    CrossRef<\/a><\/li>\n
  14. Araujo RL, Andrade BM, Padro\u0301n AS, Gaidhu MP, Perry RLS, Carvalho DP, Ceddia RB. High-Fat Diet Increases Thyrotropin and Oxygen Consumption without Altering Circulating 3,5,3\u2032-Triiodothyronine (T3) and Thyroxine in Rats: The Role of IodothyronineDeiodinases, Reverse T3 Production, and Whole-Body Fat Oxidation. Endocrinology<\/em>. 2010;151(7):3460-3469. doi:10.1210\/en.2010-0026
    \n    CrossRef<\/a><\/li>\n
  15. Landa MS, Garc\u00eda SI, Schuman ML, Burgue\u00f1o A, Alvarez AL, Saravia FE, Gemma C, Pirola CJ. Knocking down the diencephalicthyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. American Journal of Physiology-Endocrinology and Metabolism<\/em>. 2007;292(5):E1388-E1394. doi:10.1152\/ajpendo.00234.2006
    \n    CrossRef<\/a><\/li>\n
  16. Tagliaferri M, Berselli ME, Cal\u00f2 G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A. Subclinical Hypothyroidism in Obese Patients: Relation to Resting Energy Expenditure, Serum Leptin, Body Composition, and Lipid Profile. Obes Res<\/em>. 2001;9(3):196-201. doi:10.1038\/oby.2001.21
    \n    CrossRef<\/a><\/li>\n
  17. Knudsen N, Laurberg P, Rasmussen LB, B\u00fclow I, Perrild H, Ovesen L, J\u00f8rgensen T. Small Differences in Thyroid Function May Be Important for Body Mass Index and the Occurrence of Obesity in the Population. J ClinEndocrinolMetab<\/em>. 2005;90(7):4019-4024. doi:10.1210\/jc.2004-2225
    \n    CrossRef<\/a><\/li>\n
  18. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. ClinEndocrinol (Oxf)<\/em>. 2007;67(2):265-269. doi:10.1111\/j.1365-2265.2007.02874.x
    \n    CrossRef<\/a><\/li>\n
  19. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Mice Lacking the Thyroid Hormone Receptor-\u03b1 Gene Spend More Energy in Thermogenesis, Burn More Fat, and Are Less Sensitive to High-Fat Diet-Induced Obesity. Endocrinology<\/em>. 2008;149(12):6471-6486. doi:10.1210\/en.2008-0718
    \n    CrossRef<\/a><\/li>\n
  20. Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid Hormones and Their Relation to Weight Status. Horm Res Paediatr<\/em>. 2008;70(1):51-57. doi:10.1159\/000129678
    \n    CrossRef<\/a><\/li>\n
  21. Weetman AP. An update on the pathogenesis of Hashimoto\u2019s thyroiditis. J Endocrinol Invest<\/em>. 2021;44(5):883-890. doi:10.1007\/s40618-020-01477-1
    \n    CrossRef<\/a><\/li>\n
  22. Biondi B. Thyroid and Obesity: An Intriguing Relationship. J ClinEndocrinolMetab<\/em>. 2010;95(8):3614-3617. doi:10.1210\/jc.2010-1245
    \n    CrossRef<\/a><\/li>\n
  23. Fierabracci P, Pinchera A, Martinelli S, Scartabelli G, Salvetti G, Giannetti M, Pucci A, Galli G, Ricco I, Querci G, Rago T, Di Salvo C, Anselmino M, Vitti P, Santini F. Prevalence of Endocrine Diseases in Morbidly Obese Patients Scheduled for Bariatric Surgery: Beyond Diabetes. Obes Surg<\/em>. 2011;21(1):54-60. doi:10.1007\/s11695-010-0297-6
    \n    CrossRef<\/a><\/li>\n
  24. Fahed M, AbouJaoudeh MG, Merhi S, Mosleh JMB, Ghadieh R, Al Hayek S, El Hayek Fares JE. Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon. BMC EndocrDisord<\/em>. 2020;20(1):85. doi:10.1186\/s12902-020-00558-9
    \n    CrossRef<\/a><\/li>\n
  25. Duntas LH, Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid<\/em>. 2013;23(6):646-653. doi:10.1089\/thy.2011.0499
    \n    CrossRef<\/a><\/li>\n
  26. Yang CA, Chiang BL. Inflammasomes and human autoimmunity: A comprehensive review. J Autoimmun<\/em>. 2015;61:1-8. doi:10.1016\/j.jaut.2015.05.001
    \n    CrossRef<\/a><\/li>\n
  27. Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L, Biondi B. MECHANISMS IN ENDOCRINOLOGY: The crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol<\/em>. 2014;171(4):R137-R152. doi:10.1530\/EJE-14-0067
    \n    CrossRef<\/a><\/li>\n
  28. Mollaei M, Abbasi A, Hassan ZM, Pakravan N. The intrinsic and extrinsic elements regulating inflammation. Life Sci<\/em>. 2020;260:118258. doi:10.1016\/j.lfs.2020.118258
    \n    CrossRef<\/a><\/li>\n
  29. Guo Q, Wu Y, Hou Y, Liu Y, Liu T, Zhang H, Fan C, Guan H, Li Y, Shan Z, Teng W. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis. Front Immunol<\/em>. 2018;9. doi:10.3389\/fimmu.2018.01197
    \n    CrossRef<\/a><\/li>\n
  30. Hepp M, Werion A, De Greef A, de Ville de Goyet C, de Bournonville M, Behets C, Lengel\u00e9 B, Daumerie C, Mourad M, Ludgate M, Many MC, Joris V, Craps J. Oxidative Stress-Induced Sirtuin1 Downregulation Correlates to HIF-1\u03b1, GLUT-1, and VEGF-A Upregulation in Th1 Autoimmune Hashimoto\u2019s Thyroiditis. Int J Mol Sci<\/em>. 2021;22(8):3806. doi:10.3390\/ijms22083806
    \n    CrossRef<\/a><\/li>\n
  31. De Luca R, Davis PJ, Lin HY, Gionfra F, Percario ZA, Affabris E, Pedersen JZ, Marchese C, Trivedi P, Anastasiadou E, Negro R, Incerpi S. Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome. Front Cell Dev Biol<\/em>. 2021;8. doi:10.3389\/fcell.2020.614030
    \n    CrossRef<\/a><\/li>\n
  32. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM. Genomic DNA Released by Dying Cells Induces the Maturation of APCs\u2008. The Journal of Immunology<\/em>. 2001;167(5):2602-2607. doi:10.4049\/jimmunol.167.5.2602
    \n    CrossRef<\/a><\/li>\n
  33. Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity<\/em>. 2018;48(1):35-44.e6. doi:10.1016\/j.immuni.2017.11.013
    \n    CrossRef<\/a><\/li>\n
  34. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid Hormones as Modulators of Immune Activities at the Cellular Level. Thyroid<\/em>. 2011;21(8):879-890. doi:10.1089\/thy.2010.0429
    \n    CrossRef<\/a><\/li>\n
  35. Kwakkel J, Surovtseva OV, de Vries EM, Stap J, Fliers E, Boelen A. A Novel Role for the Thyroid Hormone-Activating Enzyme Type 2 Deiodinase in the Inflammatory Response of Macrophages. Endocrinology<\/em>. 2014;155(7):2725-2734. doi:10.1210\/en.2013-2066
    \n    CrossRef<\/a><\/li>\n
  36. De Vito P, Balducci V, Leone S, Percario Z, Mangino G, Davis PJ, Davis FB, Affabris E, Luly P, Pedersen JZ, Incerpi S. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players. Steroids<\/em>. 2012;77(10):988-995. doi:10.1016\/j.steroids.2012.02.018
    \n    CrossRef<\/a><\/li>\n
  37. Pearce EN. Thyroid hormone and obesity. CurrOpinEndocrinol Diabetes Obes<\/em>. 2012;19(5):408-413. doi:10.1097\/MED.0b013e328355cd6c
    \n    CrossRef<\/a><\/li>\n
  38. Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L, Biondi B. MECHANISMS IN ENDOCRINOLOGY: The crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol<\/em>. 2014;171(4):R137-R152. doi:10.1530\/EJE-14-0067
    \n    CrossRef<\/a><\/li>\n
  39. Rotondi M, Magri F, Chiovato L. Thyroid and Obesity: Not a One-Way Interaction. J ClinEndocrinolMetab<\/em>. 2011;96(2):344-346. doi:10.1210\/jc.2010-2515
    \n    CrossRef<\/a><\/li>\n
  40. Duntas LH, Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid<\/em>. 2013;23(6):646-653. doi:10.1089\/thy.2011.0499
    \n    CrossRef<\/a><\/li>\n
  41. Bjergved L, J\u00f8rgensen T, Perrild H, Laurberg P, Krejbjerg A, Ovesen L, Rasmussen LB, Knudsen N. Thyroid Function and Body Weight: A Community-Based Longitudinal Study. PLoS One<\/em>. 2014;9(4):e93515. doi:10.1371\/journal.pone.0093515
    \n    CrossRef<\/a><\/li>\n
  42. Obregon MJ. Thyroid Hormone and Adipocyte Differentiation. Thyroid<\/em>. 2008;18(2):185-195. doi:10.1089\/thy.2007.0254
    \n    CrossRef<\/a><\/li>\n
  43. L\u00f3pez M, Varela L, V\u00e1zquez MJ, Rodr\u00edguez-Cuenca S, Gonz\u00e1lez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, de Morentin PBM, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Ore\u0161i\u010d M, Chatterjee K, Saha AK, Rahmouni K, Di\u00e9guez C, Vidal-Puig A. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med<\/em>. 2010;16(9):1001-1008. doi:10.1038\/nm.2207
    \n    CrossRef<\/a><\/li>\n
  44. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA. Diet-Induced Obesity Causes Severe but Reversible Leptin Resistance in ArcuateMelanocortin Neurons. Cell Metab<\/em>. 2007;5(3):181-194. doi:10.1016\/j.cmet.2007.02.004
    \n    CrossRef<\/a><\/li>\n
  45. Nillni EA. Regulation of ProhormoneConvertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin. Endocrinology<\/em>. 2007;148(9):4191-4200. doi:10.1210\/en.2007-0173
    \n    CrossRef<\/a><\/li>\n
  46. Mullur R, Liu YY, Brent GA. Thyroid Hormone Regulation of Metabolism. Physiol Rev<\/em>. 2014;94(2):355-382. doi:10.1152\/physrev.00030.2013
    \n    CrossRef<\/a><\/li>\n
  47. Refetoff S. Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat ClinPractEndocrinolMetab<\/em>. 2008;4(1):1-1. doi:10.1038\/ncpendmet0703
    \n    CrossRef<\/a><\/li>\n
  48. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res ClinEndocrinolMetab<\/em>. 2007;21(2):277-305. doi:10.1016\/j.beem.2007.03.005
    \n    CrossRef<\/a><\/li>\n
  49. Albanes D. Caloric intake, body weight, and cancer: A review. Nutr Cancer<\/em>. 1987;9(4):199-217. doi:10.1080\/01635588709513929
    \n    CrossRef<\/a><\/li>\n
  50. Maso LD, Vecchia C La, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E. ds. Cancer Causes and Control<\/em>. 2000;11(2):137-144. doi:10.1023\/A:1008938520101
    \n    CrossRef<\/a><\/li>\n
  51. Franceschi S, Talamini R, Fassina A, Bidoli E. Diet and Epithelial Cancer of the Thyroid Gland. Tumori Journal<\/em>. 1990;76(4):331-338. doi:10.1177\/030089169007600406
    \n    CrossRef<\/a><\/li>\n
  52. Franceschi S, Levi F, Negri E, Fassina A, La Vecchia C. Diet and thyroid cancer: A pooled analysis of four european case\u2010control studies. Int J Cancer<\/em>. 1991;48(3):395-398. doi:10.1002\/ijc.2910480315
    \n    CrossRef<\/a><\/li>\n
  53. Bianco AC, McAninch EA. The role of thyroid hormone and brown adipose tissue in energy homeostasis. Lancet Diabetes Endocrinol<\/em>. 2013;1(3):250-258. doi:10.1016\/S2213-8587(13)70069-X
    \n    CrossRef<\/a><\/li>\n
  54. Nicholls DG. The physiological regulation of uncoupling proteins. BiochimicaetBiophysicaActa (BBA) – Bioenergetics<\/em>. 2006;1757(5-6):459-466. doi:10.1016\/j.bbabio.2006.02.005
    \n    CrossRef<\/a><\/li>\n
  55. Ukropec J, Anunciado RP, Ravussin Y, Hulver MW, Kozak LP. UCP1-independent Thermogenesis in White Adipose Tissue of Cold-acclimated Ucp1-\/- Mice. Journal of Biological Chemistry<\/em>. 2006;281(42):31894-31908. doi:10.1016\/S0021-9258(19)84104-2
    \n    CrossRef<\/a><\/li>\n
  56. Yavuz S, Salgado Nunez del Prado S, Celi FS. Thyroid Hormone Action and Energy Expenditure. J Endocr Soc<\/em>. 2019;3(7):1345-1356. doi:10.1210\/js.2018-00423.
    \n    CrossRef<\/a><\/li>\n
  57. Gathercole LL, Lavery GG, Morgan SA, Cooper MS, Sinclair AJ, Tomlinson JW, Stewart PM. 11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocrine reviews. 2013 Aug 1;34(4):525-55.
    \n    CrossRef<\/a><\/li>\n
  58. Martins IJ. Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations.<\/li>\n
  59. Martins IJ. Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J Diabetes Metab Disord. 2017;4(1):1-9.
    \n    CrossRef<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction Thyroid dysfunction is mostly associated with weight gain along […]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[128],"tags":[],"class_list":["post-66991","post","type-post","status-publish","format-standard","hentry","category-vol18no3"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/66991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=66991"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/66991\/revisions"}],"predecessor-version":[{"id":68306,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/66991\/revisions\/68306"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=66991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=66991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=66991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}